Philadelphia, Pennsylvania 19103
Christopher I. Halliday is a partner in Morgan Lewis's Intellectual Property Practice. Mr. Halliday's current practice is concentrated primarily on patent issues in the biotechnology arts. Mr. Halliday also has experience in the preparation and prosecution of pharmaceutical, chemical, chemical battery and catalyst patent applications, as well as opinions involving infringement, validity, freedom to operate, licensing and litigation.
Mr. Halliday represented numerous indigent clients before the courts of New Hampshire. To date, Mr. Halliday’s varied work experience also includes time with the New Hampshire Office of the Attorney General, the New Hampshire Office of the Public Defender, as well as with SmithKlineBeecham Pharmaceuticals (now GlaxoSmithKline).
Prior to joining Morgan Lewis, Mr. Halliday was employed as an associate at an IP boutique law firm in the Philadelphia area.
Mr. Halliday is admitted to practice in Pennsylvania and before the U.S. Patent and Trademark Office.
|Areas of Practice||1) Intellectual Property, 2) IP Issues in Business Transactions, 3) Licensing, 4) Life Sciences, 5) Chemistry & Life Sciences Patents, 6) Patent, 7) Life Sciences Transactions and 8) Life Sciences and Healthcare|
|Law School||Franklin Pierce Law Center|
|Education||Pennsylvania State University, 1996, B.S.|
|Bar Member / Association||State Bar Of Pennsylvania|
|Most recent firm||Morgan, Lewis & Bockius LLP|
Ms. Fitzgerald represents employers in a wide range of industries, including the entertainment, financial services, hospitality, manufacturing, retail, and transportation industries.
Ms. Shander advises public and private company clients as well as private equity funds, with an emphasis on mergers and acquisitions, dispositions, and financing transactions.